MSB 2.03% $1.45 mesoblast limited

Ann: MSB Reports Q3 Financial Results and Operational Highlights, page-265

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 7,958 Posts.
    lightbulb Created with Sketch. 631
    Again I feel as though nothing that has been said in the last few years has sunk in
    The Ryoncil phase 3 trial met it’s endpoints….so where do you link your theoretical failure of Mesoblast to Osiris to where we are now
    In fact I might opine that each trial has been a scientific journey of discovery and as a consequence the upcoming PDUFA date might usher a new form of medicine upon approval which is the complete opposite to what you just posted
    Last edited by stocksa: 28/05/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.45
Change
-0.030(2.03%)
Mkt cap ! $1.655B
Open High Low Value Volume
$1.48 $1.51 $1.43 $6.613M 4.498M

Buyers (Bids)

No. Vol. Price($)
1 2482 $1.45
 

Sellers (Offers)

Price($) Vol. No.
$1.46 27045 2
View Market Depth
Last trade - 16.10pm 18/10/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.